Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...

A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...

When transvenous pacing is unsuitable, leadless cardiac pacemaker implantation can be used during the evidence generation period for dual-chamber pacing or right atrial pacing alone for ...

Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...

Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...

Patients receiving leadless pacemakers experience overall fewer short-term and mid-term complications than those receiving traditional transvenous pacemakers, a new study found. Patients receiving ...

Despite being at higher risk of complications overall, Medicare beneficiaries who receive a Micra leadless pacemaker (Medtronic) fare better than those implanted with traditional transvenous systems, ...

The human heart rate is under the influence of various hormonal and neural control mechanisms. Normally, conduction of an electrical impulse through the heart begins at the sinoatrial (SA) node and ...

An experimental, leadless pacemaker housing is able to partially recharge the device’s battery by generating electrical energy from heartbeats. The device generated about 10% of the energy needed to ...

There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...